Hypolipidemic, uricosuric, and thyroxine-displacing effects of MK-185 (halofenate).
D000328:Adult; D000368:Aged; D001796:Blood Protein Disorders / Q000188:drug therapy*; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D005260:Female; D006016:Glycolates / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007455:Iodine / Q000097:blood; D007456:Iodine Isotopes; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011485:Protein Binding / Q000187:drug effects; D013974:Thyroxine / Q000097:blood; D014280:Triglycerides / Q000097:blood*; D014527:Uric Acid / Q000097:blood
D006016:Glycolates; D007456:Iodine Isotopes; D008074:Lipoproteins; D010919:Placebos; D014280:Triglycerides; D014527:Uric Acid; D007455:Iodine; D002784:Cholesterol; D013974:Thyroxine